Masaaki Murakami

Impact of Olmesartan on Progression of Coronary Atherosclerosis

Atsushi Hirohata, Keizô Yamamoto, Toru Miyoshi et al. · Journal of the American College of Cardiology · 2010 · 122 citations

Vascular Disease, Coronary Atherosclerosis, Cardiovascular Disease +6

Implementation of evidence-based treatment for schizophrenic disorders: two-year outcome of an international field trial of optimal treatment.

Ian R. H. Falloon, Isabel Montero, Mehmet Z. Sungur et al. · PubMed · 2004 · 121 citations

Psychotherapy, International Field Trial, Evidence-based Intervention +17

Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.

Satoshi Hirohata, Shozo Kusachi, Masaaki Murakami et al. · Heart · 1997 · 90 citations · Full text

Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation

Hirosuke Yamaji, Takashi Murakami, Kazuyoshi Hina et al. · Clinical Drug Investigation · 2013 · 54 citations

Thrombosis, Heart Failure, Dabigatran Etexilate +10

Deinstitutionalization of Long-Stay Patients with Schizophrenia: The 2-Year Social and Clinical Outcome of a Comprehensive Intervention Program in Japan

Yonosuke Ryu, Masafumi Mizuno, Kei Sakuma et al. · Australian & New Zealand Journal of Psychiatry · 2006 · 49 citations